Raymond James & Associates’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $301K | Sell |
32,780
-5,461
| -14% | -$45.2K | ﹤0.01% | 3400 |
|
|
2024
Q2 | $374K | Sell |
38,241
-3,114
| -8% | -$38K | ﹤0.01% | 3246 |
|
|
2024
Q1 | $624K | Sell |
41,355
-134,255
| -76% | -$2.44M | ﹤0.01% | 2917 |
|
|
2023
Q4 | $3.78M | Sell |
175,610
-52,628
| -23% | -$971K | ﹤0.01% | 1709 |
|
|
2023
Q3 | $4.24M | Buy |
228,238
+2,029
| +0.9% | +$47.4K | ﹤0.01% | 1563 |
|
|
2023
Q2 | $5.73M | Buy |
226,209
+6,907
| +3% | +$174K | ﹤0.01% | 1391 |
|
|
2023
Q1 | $5.68M | Buy |
219,302
+11,926
| +6% | +$319K | ﹤0.01% | 1383 |
|
|
2022
Q4 | $4.9M | Sell |
207,376
-16,126
| -7% | -$435K | ﹤0.01% | 1411 |
|
|
2022
Q3 | $5.67M | Buy |
223,502
+432
| +0.2% | +$15.2K | 0.01% | 1286 |
|
|
2022
Q2 | $7.41M | Sell |
223,070
-12,126
| -5% | -$515K | 0.01% | 1152 |
|
|
2022
Q1 | $17M | Buy |
235,196
+13,018
| +6% | +$938K | 0.01% | 779 |
|
|
2021
Q4 | $20.4M | Sell |
222,178
-22,241
| -9% | -$2.66M | 0.02% | 734 |
|
|
2021
Q3 | $31M | Sell |
244,419
-5,049
| -2% | -$735K | 0.03% | 515 |
|
|
2021
Q2 | $41.5M | Sell |
249,468
-12,009
| -5% | -$1.95M | 0.04% | 411 |
|
|
2021
Q1 | $47.5M | Sell |
261,477
-21,727
| -8% | -$5.04M | 0.05% | 334 |
|
|
2020
Q4 | $56.6M | Buy |
283,204
+1,385
| +0.5% | +$282K | 0.06% | 259 |
|
|
2020
Q3 | $61.8M | Buy |
281,819
+22,996
| +9% | +$4.87M | 0.08% | 208 |
|
|
2020
Q2 | $49.4M | Buy |
258,823
+16,711
| +7% | +$2.93M | 0.07% | 245 |
|
|
2020
Q1 | $37.5M | Sell |
242,112
-482
| -0.2% | -$56.1K | 0.06% | 261 |
|
|
2019
Q4 | $20.3M | Sell |
242,594
-4,993
| -2% | -$380K | 0.03% | 574 |
|
|
2019
Q3 | $16.8M | Buy |
247,587
+11,777
| +5% | +$775K | 0.02% | 619 |
|
|
2019
Q2 | $15.7M | Buy |
235,810
+22,078
| +10% | +$1.29M | 0.02% | 639 |
|
|
2019
Q1 | $11.9M | Buy |
213,732
+29,746
| +16% | +$1.82M | 0.02% | 727 |
|
|
2018
Q4 | $9.12M | Sell |
183,986
-33,291
| -15% | -$2.04M | 0.02% | 796 |
|
|
2018
Q3 | $18.8M | Sell |
217,277
-10,956
| -5% | -$781K | 0.03% | 556 |
|
|
2018
Q2 | $13.2M | Buy |
228,233
+5,777
| +3% | +$282K | 0.02% | 678 |
|
|
2018
Q1 | $8.96M | Buy |
222,456
+106,743
| +92% | +$4.03M | 0.02% | 840 |
|
|
2017
Q4 | $4.03M | Buy |
115,713
+3,589
| +3% | +$119K | 0.01% | 1246 |
|
|
2017
Q3 | $3.72M | Buy |
112,124
+52,507
| +88% | +$1.72M | 0.01% | 1245 |
|
|
2017
Q2 | $2.07M | Buy |
59,617
+9,345
| +19% | +$272K | ﹤0.01% | 1554 |
|
|
2017
Q1 | $1.26M | Buy |
+50,272
| New | +$1.05M | ﹤0.01% | 1828 |
|
Other funds holding TDOC
RCMNY
